← Back to home

Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL)

Clinical trials for Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL) explained in plain language.

Never miss a new study

Get alerted when new Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL) trials appear

Sign up with your email to follow new studies for Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental lymphoma drug ASTX660 tested in tiny, terminated trial

Disease control Stopped early

This early-phase trial tested the drug ASTX660 in just 8 people with T-cell lymphoma that had returned or not responded to prior treatments. The study aimed to find a safe dose and check for side effects, but it was stopped early. Because it was so small and incomplete, we cannot…

Matched conditions: RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA(PTCL),CUTANEOUS T-CELL LYMPHOMA(CTCL),ADULT T-CELL LEUKEMIA/LYMPHOMA(ATLL)

Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL)

Get alerted when new Relapsed or refractory peripheral T-cell lymphoma(PTCL),cutaneous T-cell lymphoma(CTCL),adult T-cell leukemia/lymphoma(ATLL) trials appear

Experimental lymphoma drug ASTX660 tested in tiny, terminated trial